Trends in cervical cancer incidence and mortality in Bulgaria, Estonia, Latvia, Lithuania and Romania

Tumori

Volumn 96, Issue 4, 2010, Pages 517-523

  Arbyn, Marc ^a   Antoine, Jerome ^a   Valerianova, Zdravka ^b   Mägi, Margit ^c   Stengrevics, Aivars ^d   Smailyte, Giedre ^e   Suteu, Ofelia ^f,g   Micheli, Andrea ^h  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b Bulgarian Cancer Registry   (Bulgaria)

^c Estonian Cancer Registry   (Estonia)

^d Latvian Cancer Registry   (Latvia)

^e Lithuanian Cancer Registry   (Lithuania)

^f IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^g Institute of Oncology   (Romania)

^h NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Bulgaria; Cervical cancer; Estonia; Europe; Incidence; Latvia; Lithuania; Mortality; Romania; Trend analysis

Indexed keywords

ADULT; AGED; ARTICLE; BULGARIA; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; DEATH CERTIFICATE; ESTONIA; FEMALE; HUMAN; LATVIA; LITHUANIA; REGRESSION ANALYSIS; ROMANIA; TREND STUDY; UTERINE CERVIX CANCER; WORLD HEALTH ORGANIZATION; AGE DISTRIBUTION; INCIDENCE; MASS SCREENING; MIDDLE AGED; MORTALITY; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BULGARIA; ESTONIA; FEMALE; HUMANS; INCIDENCE; LATVIA; LITHUANIA; MASS SCREENING; MIDDLE AGED; ROMANIA; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 77957189230     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089161009600402     Document Type: Article

References (42)

1. Arbyn M, Raifu AO, Autier P, Ferlay J: Burden of cervical cancer in Europe: estimates for 2004. Ann Oncol, 18: 1708-1715, 2007.
2. Arbyn M, Autier P, Ferlay J: Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol, 18: 1425-1427, 2007.
3. Ferlay J, Bray F, Pisani P, Parkin DM: GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0. IARCPress, Lyon, 2004.
4. EUROCHIP: European Cancer Health Indicator Project. Available at http://www.tumori.net/eurochip/ (accessed 21 March 2010).
5. European Commission: European Guidelines for Quality Assurance in Cervical Cancer Screening. 2nd ed. Office for Official Publications of the European Communities, Luxembourg, 2008.
6. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Wiener H, Herbert A, von Karsa L: European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition - Summary Document. Ann Oncol, 21: 448-458, 2010.
7. Arbyn M, Raifu AO, Antoine J: Trends of cervical cancer mortality in Europe. IPH/EPI-REPORTS 2009-07: 1-54, 2009.
8. Arbyn M, Antoine J, Mägi M, Smailyte G, Stengrevics A, Suteu O, Valerianova Z, Bray F, Weiderpass E: Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania. Int J Cancer 2010 (epub ahead of print).
9. Arbyn M, Raifu AO, Bray F, Weiderpass E, Anttila A: Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer, 45: 2640-2648, 2009.
10. Waterhouse JAH, Muir CS, Shanmugaratnam K: Cancer Incidence in Five Continents. 4 ed. International Agency for Research on Cancer, Lyon, 1976.
11. National Cancer Institute: Join Point Regression Programme. Version 3.2. (Software produced by the Statistical Research and Application Branch), 2008.
12. Lerman PM: Fitting segmented regression models by grid search. Appl Stat, 29: 77-84, 1980.
13. Kim H-J, Fay MP, Feuer EJ, Midthune DN: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 19: 335-351, 2000.
14. Devesa SS, Donaldson J, Fears T: Graphical presentation of trends in rates. Am J Epidemiol, 141: 300-304, 1995.
15. Arbyn M, Van Oyen H, Sartor F, Tibaldi F, Molenberghs G: Description of the influence of age, period and cohort effects on cervical cancer mortality by loglinear Poisson models (Belgium, 1955-94). Arch Public Health, 60: 73-100, 2002.
16. Beral V: Cancer of the cervix: a sexually transmitted infection? Lancet, 25: 1037-1040, 1974.
17. Osmond C, Gardner MJ: Age, Period and Cohort Models Applied to Cancer Mortality Rates. Stat Med, 1: 245-259, 1982.
18. IARC Monograph Working Group: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 90: Human Papillomaviruses. IARCPress, Lyon, 2007.
19. IARC: Cervix Cancer Screening. IARC Handbooks of Cancer Prevention. Vol. 10. IARCPress, Lyon, 2005.
20. Laara E, Day NE, Hakama M: Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet, 1: 1247-1249, 1987. (Pubitemid 17070815)
21. Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Moller H, Hakama M, Parkin DM: Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev, 14: 677-686, 2005. (Pubitemid 40489214)
22. Zakelj MP, Kirn VP, Skrlec F, Selb J: Can we rely on cancer mortality data? Checking the validity of cervical cancer mortality data for Slovenia. Radiol Oncol, 35: 243-247, 2002. (Pubitemid 34019576)
23. Suzan F, Séblain C, Boussac-Rarebska M, Poillot ML, Arveux P, Laurent F, Carré N: Survey on the distribution of "uterus cancer, cervix corpus cancer and not otherwise specified cancer" among death certificates for cervix cancer and corpus uteri cancer, France. Bull Epidemiol Hebdom, 9: 79-81, 2007.
24. Capocaccia R, Martina L, Inghelmann R, Crocetti E, De L, V, Falcini F, Guzzinati S, Rosso S, Tagliabue G, Tumino R, Vercelli M, Zanetti R, De Angelis R: A method to estimate mortality trends when death certificates are imprecisely coded: an application to cervical cancer in Italy. Int J Cancer, 124: 1200-1205, 2009.
25. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000. The global picture. Eur J Cancer, 37: 4-66, 2001.
26. Laukkanen P, Koskela P, Pukkala E, Dillner J, Laara E, Knekt P, Lehtinen M: Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland. J Gen Virol, 84: 2105-2109, 2003.
27. Lehtinen M, Kaasila M, Pasanen K, Patama T, Palmroth J, Laukkanen P, Pukkala E, Koskela P: Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s. Int J Cancer, 119: 2612-2619, 2006. (Pubitemid 44691316)
28. International Collaboration of Epidemiological studies of cervical cancer: Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer, 118: 1481-1495, 2006.
29. Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, Franceschi S, Beral V: Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet, 361: 1159-1167, 2003.
30. Quinn M, Babb P, Jones J: Effect of Screening on Incidence an Mortality from Cancer of the Cervix in England: Evaluation Based on Routinely Collected Statistics. BMJ, 318: 904-908, 1999. (Pubitemid 29191925)
31. Nygard JF, Skare GB, Thoresen SO: The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. J Med Screen, 9: 86-91, 2002.
32. Rebolj M, van Ballegooijen M, Berkers LM, Habbema JDF: Monitoring a national cancer prevention programme: Successful changes in cervical cancer screening in the Netherlands. Int J Cancer, 120: 806-812, 2007. (Pubitemid 46175400)
33. Anttila A, Nieminen P: Cervical cancer screening programme in Finland with an example on implementing alternative screening methods. Coll Antropol, 31 (Suppl 2): 17-22, 2007.
34. Arbyn M, Geys H: Trend of cervical cancer mortality in Belgium (1954-94): tentative solution for the certification problem of not specified uterine cancer. Int J Cancer, 102: 649-654, 2002.
35. Nicula F, Anttila A, Neamtiu L, Zakelj-Primic M, Tachezy R, Chil A, Grce M, Kesic V: Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union. Eur J Cancer, 45: 2679-2684, 2009.
36. Suteu O, Lazar L, Irimie A, Nicula F, Coza D, Duma M, Pais R, Neamtiu L: Organization and implementation of cervical screening pilot programin County of Cluj, Transilvania. In: Fifth Proceedings of the International Multidisciplinary Congress EUROGIN 2003, Paris, 2003.
37. Sant M, Aareleid T, Berrino F, Bielska LM, Carli PM, Faivre J, Grosclaude P, Hedelin G, Matsuda T, Moller H, Moller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D: EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol, 14: 61-118, 2003.
38. Gondos A, Bray F, Brewster DH, Coebergh JW, Hakulinen T, Janssen-Heijnen ML, Kurtinaitis J, Brenner H: Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries. Eur J Cancer, 44(10): 1463-1475, 2008.
39. Bielska-Lasota M, Inghelmann R, Poll-Franse L, Capocaccia R: Trends in cervical cancer survival in Europe, 1983-1994: a population-based study. Gynecol Oncol, 105: 609-619, 2007.
40. Kostova P, Zlatkov V, Danon S: Five-year overall survival and prognostic factors in patients with cervical cancer in Bulgaria. J BUON, 13: 363-368, 2008.
41. Council of the European Union: Council Recommendation of 2 December 2003 on Cancer Screening. Off J Eur Union, 878: 34-38, 2003.
42. Arbyn M, Primic Zakelj M, Raifu AO, Grce M, Paraskevaidis E, Diakomanolis E, Kesic V, Nicula F, Suteu O, von Karsa L: The burden of cervical cancer in South-East Europe at the beginning of the 21st century. Coll Antropol, 31: 7-10, 2007.